Leave A Message
Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.

Canine Babesia canis Antibody Rapid Test Kit

High-Specificity Canine Babesia canis Antibody Rapid Test Kit is professional-grade veterinary POCT colloidal gold lateral flow assay for immediate, reliable qualitative detection of Babesia canis antibodies in canine whole blood, serum, or plasma.
Advantages
  • Targeted Strain Specificity
  • Critical Post-Exposure Screening
  • Instant On-Site Triage (10-Minute Results)
  •  

    Babesia Canis Antibody Rapid Test Kit

    Product Description

    Veterinary Rapid Diagnostic Test Pet Test Babesia Canis Antibody Test for Dogs

    The Canine Babesia canis Antibody Test is a lateral flow immunochromatographic assay designed for the qualitative detection of Babesia canis antibodies (BC Ab) in canine whole blood, serum, or plasma samples.

    The test provides a rapid and convenient method for screening Babesia canis exposure in dogs, supporting veterinary professionals in the assessment of canine tick-borne diseases.

    With simple operation and rapid detection performance, the product is suitable for veterinary clinics, animal hospitals, diagnostic laboratories, and canine health screening programs.

    Specifications

    Material Provided 10 BC Ab test cards
    10 Vials of assay buffer
    10 Disposable droppers
    10 Capillary droppers
    1 Instruction for use
    Product Name Babesia Canis Antibody Rapid Test
    Specimen Dog's serum, plasma and whole blood
    Assay Time 5-10 minutes
    MOQ 300 boxes
    Delivery time 3-5 days by DHL
    Packing 10 test kits/Packing box
    Storage Temperature 2-30°C
    Shelf Life 24 months
    Production Capacity 1 Million/Day
    Payment T/T, Western Union, Paypal

    Test Procedure (Visual Interpretation)

    1. Remove the test cassette from the foil pouch and place it on a clean, flat surface.
    2. Using a capillary dropper, transfer 1 drop of the prepared sample into the sample well.
    3. Add 3 drops of assay buffer into the sample well using a disposable dropper.
    4. Start the timer and read the result within 5–10 minutes.
    Test operation diagram

    Principle

    The Canine Babesia canis Antibody Test is based on a lateral flow immunochromatographic assay.

    The test cassette contains a result window with an initially invisible T (Test) line and C (Control) line for result interpretation.

    During the assay, highly specific Babesia canis antigens are used as capture and detector reagents. The detector antigen is labeled with colloidal gold particles. After the treated sample is applied to the sample well, the specimen migrates laterally along the test membrane through capillary action.

    The appearance of the C line confirms that the sample has migrated correctly and that the assay has been performed properly.

    Therefore, the test cassette provides reliable detection of Babesia canis antibodies in canine whole blood, serum, or plasma samples.

    Why Early Babesia Testing Matters

    Early detection of Babesia canis infection is critical for protecting canine health and improving treatment outcomes. Because canine babesiosis often begins with non-specific symptoms such as fever, lethargy, loss of appetite, and weakness, infected dogs may remain undiagnosed until the disease has progressed to more severe stages.

    As the parasite invades and destroys red blood cells, affected dogs can develop hemolytic anemia, jaundice, hemoglobinuria, and potentially life-threatening complications involving the liver, kidneys, and cardiovascular system. Delayed diagnosis may increase the risk of hospitalization, prolonged treatment, and poor prognosis.

    Routine Babesia testing in dogs allows veterinarians to identify infected animals before severe clinical signs develop, enabling timely intervention and more effective disease management.

    Benefits of Early Babesia Screening

    • ✔ Detect infection before severe anemia occurs
    • ✔ Support faster treatment decisions
    • ✔ Reduce the risk of organ damage and disease progression
    • ✔ Improve recovery rates and long-term health outcomes
    • ✔ Identify subclinical or asymptomatic infections
    • ✔ Monitor dogs living in tick-endemic regions
    • ✔ Screen breeding dogs and blood donors for vector-borne diseases
    • ✔ Enhance preventive healthcare and annual wellness programs

    Company Profile

    Factory

    Breakthroughs & Advantages

    We have achieved a series of breakthrough results in veterinary rapid testing. Compared with traditional methods (such as PCR or culture), our rapid tests demonstrate superior performance. Traditional methods are often time-consuming and costly, while our products offer:

    - Rapid results in approximately 15 minutes
    - Cost-effectiveness
    - Suitable for animal self-testing or use by veterinarians/farm personnel, significantly reducing waiting time

    Our Mission
    Over the years, we have remained committed to the following mission: Through continuous diagnostic research and development, provide rapid, accurate, and cost-effective diagnostic testing products.

    Technical & Ordering FAQ for Global Distributors

    Q1: Why does this test detect antibodies (Ab) instead of antigens (Ag), and what is its clinical significance?

    A: Babesia canis parasites sequester inside red blood cells, making direct antigen capture in circulating whole blood highly variable during subclinical or chronic stages. This indirect antibody (Ab) test detects the host's robust humoral immune response. It is highly effective for screening blood donors, identifying asymptomatic carriers, confirming prior tick exposure, and diagnosing dogs that have already transitioned past the hyper-acute parasitemia phase.

    Q2: Can this test kit differentiate between Babesia canis and Babesia gibsoni infections?

    A: Yes. This rapid test utilizing highly specific recombinant outer membrane proteins unique to Babesia canis (the large form of Babesia). It has zero cross-reactivity with Babesia gibsoni (the small form) antibodies. This distinct differentiation is crucial for veterinarians, as B. canis and B. gibsoni require different clinical treatment protocols and antibiotic therapies.

    Q3: If a dog shows severe acute hemolytic anemia but tests negative, how should a vet proceed?

    A: If a dog is in the hyper-acute phase immediately following a tick bite, it may take 10 to 14 days for detectable antibody titers to develop (the pre-patent period). If clinical signs like pale gums, fever, and splenomegaly are severe but the antibody test is negative, we highly recommend performing a direct blood smear evaluation, running a PCR test, or treating empirically and re-testing with this kit in 2 weeks.

    Q4: Will prior treatment with imidocarb dipropionate or doxycycline affect the antibody test results?

    A: Active medical treatment will eliminate or reduce the parasite load, but circulating IgG antibodies to Babesia canis can persist in the dog's bloodstream for several months post-recovery. Therefore, a dog may still test positive on this antibody kit after successful treatment. It should be used as a tool for exposure screening rather than a definitive marker for immediate post-treatment clearance.

    Q5: Can canine whole blood collected in EDTA, Heparin, or Citrate tubes be used on this strip?

    A: Yes. Our specialized sample extraction buffer is fully validated to accept fresh whole blood treated with standard clinic anticoagulants, including EDTA, Lithium/Sodium Heparin, or Sodium Citrate. Ensure the whole blood is thoroughly mixed before applying the micro-drop to the sample well to ensure optimal capillary flow dynamics.

    Q6: What causes a faint or weak Test (T) line, and should it be interpreted as a positive result?

    A: Yes, any visible pink or red line in the Test (T) zone within the 10-minute window—no matter how faint—constitutes a positive result. A faint line typically indicates a very early-stage seroconversion (antibody levels are just rising) or a chronic carrier with low, stabilized antibody titers.

    Q7: How does your factory minimize false positives caused by alternative tick-borne co-infections?

    A: Co-infections with other tick-borne pathogens (like Ehrlichia, Anaplasma, or Lyme disease) are incredibly common. To ensure ultimate diagnostic specificity, our manufacturing IQC process tests every batch against a reference panel of hyper-immune serum from alternative canine vector pathogens, securing a baseline specificity of 99.0% against cross-reacting agents.

    Q8: Can we request customized combinations under your OEM service (e.g., adding Ehrlichia to create a 2-in-1 combo card)?

    A: Absolutely. As a direct veterinary diagnostics manufacturer, our R&D and automated assembly lines are fully flexible. We can modify the internal layout of the plastic cassette to create customized multi-panels, such as a Babesia canis + Ehrlichia Ab dual card or a comprehensive 4-in-1 vector panel. This custom OEM path requires an adjusted development schedule and an MOQ starting at 5,000 units.

    Q9: What is the optimal storage temperature for these kits, and can they withstand tropical shipping conditions?

    A: The standard storage requirement is room temperature or refrigeration (2°C to 30°C). Do not freeze. For our global distribution partners operating in tropical or high-humidity regions, each cassette is hermetically sealed in a heavy-duty aluminum foil pouch with a high-grade molecular sieve desiccant to prevent moisture spikes or heat degradation during standard international air transport.

    Q10: Do you provide official verification documentation and dossiers to clear regional customs or Ministry registration?

    A: Yes. We provide our authorized global distributors with a comprehensive Regulatory Registration Dossier. This package includes our factory ISO 13485 certification, veterinary GMP compliance summaries, technical sheets covering antibody validation studies, and lot-specific Certificates of Analysis (COA) to guarantee a smooth import clearance process.

    Packaging and Shipping

    Packaging & Shipping
Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.

Leave A Message

Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
Start a Conversation

Hi! Click one of our members below to chat on